Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$6.01+0.63 (+11.81%)
Close on Nov 17, 2026Market cap $112.45MP/E –Yield –
Trinity Biotech total assets
Total assets on the balance sheet at the end of each period.
Trinity Biotech's total assets was $105.17M at Dec 31, 2025. For fiscal 2025 it was $105.17M, up 1.8% from the year before. The highest annual figure on record is $249.59M in fiscal 2016.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $105.17M | +1.8% |
| FY2024 | Dec 31, 2024 | $103.29M | +73.8% |
| FY2023 | Dec 31, 2023 | $59.44M | -35.5% |
| FY2022 | Dec 31, 2022 | $92.10M | -22.5% |
| FY2021 | Dec 31, 2021 | $118.90M | -8.8% |
| FY2020 | Dec 31, 2020 | $130.40M | -0.5% |
| FY2019 | Dec 31, 2019 | $131.07M | -13.6% |
| FY2018 | Dec 31, 2018 | $151.66M | -21.4% |
| FY2017 | Dec 31, 2017 | $192.97M | -22.7% |
| FY2016 | Dec 31, 2016 | $249.59M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $105.17M | +76.9% |
| Q2 FY2025 | Jun 30, 2025 | $99.63M | +8.2% |
| Q4 FY2024 | Dec 31, 2024 | $103.29M | -3.6% |
| Q2 FY2024 | Jun 30, 2024 | $94.36M | -20.6% |
| Q4 FY2023 | Dec 31, 2023 | $59.44M | -54.4% |
| Q4 FY2022 | Dec 31, 2022 | $92.10M | -29.7% |
| Q2 FY2022 | Jun 30, 2022 | $107.14M | -29.4% |
| Q4 FY2021 | Dec 31, 2021 | $118.90M | -38.9% |
| Q4 FY2020 | Dec 31, 2020 | $130.40M | -33.0% |
| Q4 FY2019 | Dec 31, 2019 | $131.07M | -32.1% |
| Q4 FY2018 | Dec 31, 2018 | $151.66M | -39.2% |
| Q2 FY2018 | Jun 30, 2018 | $194.45M | – |
| Q1 FY2018 | Mar 31, 2018 | $194.68M | – |
| Q4 FY2017 | Dec 31, 2017 | $192.97M | – |
| Q4 FY2016 | Dec 31, 2016 | $249.59M | – |
See a number that looks wrong?